These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 22940629

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO, Gabreëls-Festen AA, Stoll G, Müller HW.
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [Abstract] [Full Text] [Related]

  • 3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW.
    J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
    Lee JS, Lee JY, Song DW, Bae HS, Doo HM, Yu HS, Lee KJ, Kim HK, Hwang H, Kwak G, Kim D, Kim S, Hong YB, Lee JM, Choi BO.
    Nucleic Acids Res; 2020 Jan 10; 48(1):130-140. PubMed ID: 31713617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.
    Chao HC, Chou CT, Lee YC, Lin KP.
    J Neurol Sci; 2015 Nov 15; 358(1-2):213-20. PubMed ID: 26349404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
    Hanemann CO, Gabreëls-Fasten AA, Müller HW, Stoll G.
    Brain; 1996 Oct 15; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Small axons relative to number of myelin lamellae in Charcot-Marie-Tooth disease 1A with peripheral myelin protein 22 gene duplication.
    Ohnishi A, Yamamoto T, Ikeda M.
    J UOEH; 2000 Jun 01; 22(2):107-17. PubMed ID: 10862406
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SARM1 knockout does not rescue neuromuscular phenotypes in a Charcot-Marie-Tooth disease Type 1A mouse model.
    Moss KR, Johnson AE, Bopp TS, Yu AT, Perry K, Chung T, Höke A.
    J Peripher Nerv Syst; 2022 Mar 01; 27(1):58-66. PubMed ID: 35137510
    [Abstract] [Full Text] [Related]

  • 19. Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.
    Verhamme C, King RH, ten Asbroek AL, Muddle JR, Nourallah M, Wolterman R, Baas F, van Schaik IN.
    J Neuropathol Exp Neurol; 2011 May 01; 70(5):386-98. PubMed ID: 21487305
    [Abstract] [Full Text] [Related]

  • 20. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G, Study Group for Hereditary Neuropathy in Japan.
    Brain; 2003 Jan 01; 126(Pt 1):134-51. PubMed ID: 12477701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.